Pimasertib

Contact us
TargetMol
Product Code: TAR-T6131
Supplier: TargetMol
CodeSizePrice
TAR-T6131-2mg2mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6131-5mg5mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6131-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6131-10mg10mg£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6131-25mg25mg£145.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6131-50mg50mg£191.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6131-100mg100mg£256.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6131-200mg200mg£311.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1
❮❯

Documents

Further Information

Bioactivity:
Pimasertib is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
CAS:
1236699-92-5
Formula:
C15H15FIN3O3
Molecular Weight:
431.2
Pathway:
MAPK
Purity:
0.9825
SMILES:
c1cc(c(cc1I)F)Nc1c(ccnc1)C(=O)NC[C@@H](CO)O
Target:
MEK

References

Yoon J, et al. Cancer Res, 2011, 71(2), 445-453 Kim K, et al. Br J Haematol, 2010, 149(4), 537-549. Gilmartin AG, Clin Cancer Res, 2011, 17(5), 989-1000.